Pompili, Maurizio
Article History
Received: 5 December 2023
Accepted: 4 January 2024
First Online: 16 January 2024
Change Date: 25 January 2024
Change Type: Update
Change Details: The apostrophe after the name “Edwin Shneidman” has been removed in abstract section
Declarations
:
: Not applicable.
: The authors declare no competing interests. He wishes to disclose that in the last 2 years, he has received lecture and advisory board honoraria or has engaged in clinical trial activities with Angelini Pharma, Janssen, Lundbeck, MSD, Otsuka, Rovi, Pfizer, Fidia, Viatris and Recordati, all of which are unrelated to this article.